DE3583296D1 - Oncofetal spezifische monoklonale antikoerper, deren herstellung und verwendung. - Google Patents

Oncofetal spezifische monoklonale antikoerper, deren herstellung und verwendung.

Info

Publication number
DE3583296D1
DE3583296D1 DE8585906109T DE3583296T DE3583296D1 DE 3583296 D1 DE3583296 D1 DE 3583296D1 DE 8585906109 T DE8585906109 T DE 8585906109T DE 3583296 T DE3583296 T DE 3583296T DE 3583296 D1 DE3583296 D1 DE 3583296D1
Authority
DE
Germany
Prior art keywords
oncofetal
production
monoclonal antibodies
specific monoclonal
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585906109T
Other languages
English (en)
Inventor
H Coggin
J Payne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of South Alabama
Original Assignee
University of South Alabama
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of South Alabama filed Critical University of South Alabama
Application granted granted Critical
Publication of DE3583296D1 publication Critical patent/DE3583296D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20—Immunohistochemistry assay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864—Monoclonal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE8585906109T 1984-11-21 1985-11-15 Oncofetal spezifische monoklonale antikoerper, deren herstellung und verwendung. Expired - Fee Related DE3583296D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/673,794 US4686180A (en) 1984-11-21 1984-11-21 Onco-fetal specific monoclonal antibodies, methods of preparation and use
PCT/US1985/002258 WO1986003223A1 (en) 1984-11-21 1985-11-15 Onco-fetal specific monoclonal antibodies, methods of preparation and use

Publications (1)

Publication Number Publication Date
DE3583296D1 true DE3583296D1 (de) 1991-07-25

Family

ID=24704144

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585906109T Expired - Fee Related DE3583296D1 (de) 1984-11-21 1985-11-15 Oncofetal spezifische monoklonale antikoerper, deren herstellung und verwendung.

Country Status (9)

Country Link
US (1) US4686180A (de)
EP (1) EP0203967B1 (de)
JP (1) JPH0683666B2 (de)
AU (1) AU593229B2 (de)
CA (1) CA1307218C (de)
DE (1) DE3583296D1 (de)
FI (1) FI92222C (de)
NO (1) NO170691C (de)
WO (1) WO1986003223A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675287A (en) * 1984-07-26 1987-06-23 Scripps Clinic And Research Foundation Monoclonal antibody directed to human ganglioside GD2
FR2571146B1 (fr) * 1984-10-01 1988-02-26 Centre Nat Rech Scient Antigenes carcino-foetaux du pancreas humain et un procede de purification, antiserum contre ces antigenes et son procede de preparation et compositions diagnostiques les contenant
US5320941A (en) * 1986-06-06 1994-06-14 Dallan Young DNA sequence encoding mas onhcogene, polypeptides encoded therefrom and diagnostic and other methods based therefrom
JPH0859089A (ja) * 1994-08-18 1996-03-05 Towa Kogyo Kk ボビン搬送用トレイ
ATE432339T1 (de) 1996-04-05 2009-06-15 Univ South Alabama Verwendung von onkofötal-antigen spezifischen cd4,cd8 zytotoxischen, suppressor t-zellen und interleukin-10
US20030124125A1 (en) * 1996-04-05 2003-07-03 South Alabama Medical Science Foundation Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10
DE10346627A1 (de) * 2003-10-08 2005-05-19 Weiss, Stefan, PD Dr. Single-chain-Antikörper gegen den 37 kDa/67 kDa Lamininrezeptor als Werkzeuge zur Diagnose und Therapie von Prionerkrankungen und Krebs, deren Herstellung und Verwendung
GB0510790D0 (en) 2005-05-26 2005-06-29 Syngenta Crop Protection Ag Anti-CD16 binding molecules
US20070048795A1 (en) * 2005-08-26 2007-03-01 Xiangming Fang Immunoaffinity separation and analysis compositions and methods
CA3209579A1 (en) 2021-01-27 2022-08-04 Innovent Biologics (Suzhou) Co., Ltd. Single-domain antibody against cd16a and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440863A (en) * 1978-02-22 1984-04-03 Duke University Breast cyst fluid protein assay
US4272504A (en) * 1978-12-14 1981-06-09 Abbott Laboratories Antibody adsorbed support method for carcinoembryonic antigen assay
US4349528A (en) * 1979-11-21 1982-09-14 The Wistar Institute Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen
DE3263249D1 (en) * 1981-08-21 1985-05-30 Hoffmann La Roche Method for the determination of carcinoembryonic antigen (cea) and suitable antibody solution for the determination
JPH0811075B2 (ja) * 1982-06-30 1996-02-07 雄治 松岡 単クローン性抗ｃｅａ抗体

Also Published As

Publication number Publication date
AU5196486A (en) 1986-06-18
NO862920L (no) 1986-07-18
FI92222C (fi) 1994-10-10
NO170691C (no) 1992-11-18
AU593229B2 (en) 1990-02-08
CA1307218C (en) 1992-09-08
JPH0683666B2 (ja) 1994-10-26
US4686180A (en) 1987-08-11
NO170691B (no) 1992-08-10
FI862978A (fi) 1986-07-18
EP0203967A4 (de) 1987-04-10
JPS62501189A (ja) 1987-05-14
WO1986003223A1 (en) 1986-06-05
EP0203967B1 (de) 1991-06-19
FI92222B (fi) 1994-06-30
EP0203967A1 (de) 1986-12-10
FI862978A0 (fi) 1986-07-18
NO862920D0 (no) 1986-07-18

Similar Documents

Publication Publication Date Title
DE3581578D1 (de) Antikoerper, herstellung und verwendung.
DE3588225T2 (de) Anti-Lymphotoxin-Antikörper, Herstellung und Verwendung
DE3682654D1 (de) Acylaminosiliciumverbindungen, deren verwendung und herstellung.
DE3579888D1 (de) Carbapenemverbindungen und deren herstellung.
DE3480794D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.
DE3788148D1 (de) Monoklonale Antikörper und deren Verwendung.
DE3785967T2 (de) Monoklonale Antikörper gegen C5A und DES-ARG74-C5A, ihre Herstellung und ihre Verwendung.
DE3577719D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.
DE3584410D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.
DE134141T1 (de) Polartikel und deren herstellung.
DE3484531D1 (de) Tetrahydrobenzotriazole, deren herstellung und verwendung.
DE3585095D1 (de) 6-alkyliden-peneme, ihre herstellung und verwendung sowie zwischenprodukte.
DE3583296D1 (de) Oncofetal spezifische monoklonale antikoerper, deren herstellung und verwendung.
DE3577707D1 (de) 3-pyrazolo(1,5-a)pyridinium-cephemverbindungen, deren herstellung und verwendung.
DE3682491D1 (de) Immobilisierter c-peptid-antikoerper, seine herstellung und verwendung.
DE3766441D1 (de) Anilinotriazine und deren verwendung.
DE3581981D1 (de) Polysaccharid-ron-substanz, ihre herstellung und verwendung.
DE3577870D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.
ATE43356T1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.
DE3673794D1 (de) Monoklonale antikoerper gegen gamma-interferon, ihre herstellung und verwendung.
DE68904336T2 (de) Anti-humankrebsproteinkomplexe, deren herstellung und verwendung.
ATE64616T1 (de) Oncofetal spezifische monoklonale antikoerper, deren herstellung und verwendung.
DE3575721D1 (de) Pyrimidinonderivate, deren herstellung und verwendung.
DE3381313D1 (de) Dihydropyridinderivate, deren herstellung und verwendung.
ATE15367T1 (de) N-hydroxyaethylmakrocyclische polyamine, deren herstellung und verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee